The Effect of Rotigotine Extended-Release Microspheres Alone or With Celecoxib on the Inflammatory Pain
Clinical trials of rotigotine extended-release microspheres (RTGT-MS), which provides a sustained release of rotigotine for near 2 weeks in vivo, have been conducted in the treatment of Parkinson’s disease (PD). This study was to investigate the analgesic effect of RTGT-MS, and to know whether RTGT-...
Main Authors: | Keke Li, Yijia Zhang, Enming Tian, Zikai Liu, Tian Wang, Fenghua Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.594387/full |
Similar Items
-
The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease
by: Marina Romanovna Nodel
Published: (2013-11-01) -
Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson’s disease and its evolution study
by: Aiping Wang, et al.
Published: (2016-05-01) -
Effects of rotigotine on clinical symptoms, quality of life and sleep hygiene adequacy in hemodialysis-associated restless legs syndrome
by: Vicent Esteve, et al.
Published: (2018-01-01) -
BEHAVIORAL AND NEUROPHYSIOLOGICAL EFFECTS OF TRANSDERMAL ROTIGOTINE IN ATYPICAL PARKINSONISM
by: Davide v Moretti, et al.
Published: (2014-06-01) -
Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery
by: Angeline Shak. Tzeyung, et al.
Published: (2019-01-01)